Statistics

Total Visits

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)96

Select a period of time:

Number of views in the range

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)24

Views

Views
December 20254
January 20261
February 20260
March 20263
April 20262
May 202613
June 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
United Kingdom5
Argentina4
Mexico3
Colombia1
Ecuador1
Spain1
France1
Netherlands1
Peru1
 

Top cities views

Views
Beaufort1
Benicarló1
Buffalo1
Culiacán1
Danbury1
Des Moines1
Huizen1
Irapuato1
Jesús María1
Lansdowne1